ºÚÁÏÍø

Connor completed a BSc (Hons) in Biochemistry at Newcastle University in 2015. He then moved to the University of Manchester to study the regulatory chromatin landscape of oesophageal adenocarcinoma. Connor came to Cambridge in 2020 to work on onco-metabolites in renal cancers and how they influence gene expression networks. His current focus is on the reprogramming potential of human transcription factors and their role in cancer.